Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             38 results found
no title author magazine year volume issue page(s) type
1 A heterologous prime–boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis Gonzalo, Rosa M
2002
20 7-8 p. 1226-1231
6 p.
article
2 A new accelerated vaccination schedule for rapid protection against hepatitis A and B Nothdurft, H.D
2002
20 7-8 p. 1157-1162
6 p.
article
3 Announcement: Microarrays Immune Response 2002
20 7-8 p. XXXVI-
1 p.
article
4 Announcement: Therapeutic Vaccine agains 2002
20 7-8 p. XXXVII-
1 p.
article
5 A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants Dus Santos, Marı́a J
2002
20 7-8 p. 1141-1147
7 p.
article
6 A simple selection system for construction of recombinant gD-negative pseudorabies virus as a vaccine vector Shiau, Ai-Li
2002
20 7-8 p. 1186-1195
10 p.
article
7 Author Index (to Vol. 19,2001) 2002
20 7-8 p. I-XVI
nvt p.
article
8 Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections Monath, Thomas P
2002
20 7-8 p. 1004-1018
15 p.
article
9 Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines Ragupathi, Govindaswami
2002
20 7-8 p. 1030-1038
9 p.
article
10 Construction and in vitro characterization of a molecularly cloned human immunodeficiency virus type 1 library Mukai, Tetsu
2002
20 7-8 p. 1181-1185
5 p.
article
11 Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint Ho, Jason
2002
20 7-8 p. 1169-1180
12 p.
article
12 Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses Kemp, J.M
2002
20 7-8 p. 1089-1098
10 p.
article
13 Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine Konishi, Eiji
2002
20 7-8 p. 1058-1067
10 p.
article
14 DNA vaccination with map1 gene followed by protein boost augments protection against challenge with Cowdria ruminantium, the agent of heartwater Nyika, Aceme
2002
20 7-8 p. 1215-1225
11 p.
article
15 Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime–boost immunisation regimes Gilbert, Sarah C
2002
20 7-8 p. 1039-1045
7 p.
article
16 Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults Treanor, John
2002
20 7-8 p. 1099-1105
7 p.
article
17 Evaluation of immunization practices in Naples–Italy Simonetti, Andrea
2002
20 7-8 p. 1046-1049
4 p.
article
18 Familial adverse events after measles–mumps–rubella (MMR) vaccination Guala, Andrea
2002
20 7-8 p. 991-
1 p.
article
19 Frequency and causes of vaccine wastage Setia, Sabeena
2002
20 7-8 p. 1148-1156
9 p.
article
20 Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing Pugachev, Konstantin V
2002
20 7-8 p. 996-999
4 p.
article
21 Human therapeutic cocaine vaccine: safety and immunogenicity Kosten, Thomas R
2002
20 7-8 p. 1196-1204
9 p.
article
22 Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillance Pebody, R.G
2002
20 7-8 p. 1134-1140
7 p.
article
23 Impact of a regional Hib vaccination programme in Italy Gallo, Giovanni
2002
20 7-8 p. 993-995
3 p.
article
24 Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis Buddle, Bryce M
2002
20 7-8 p. 1126-1133
8 p.
article
25 Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies Patil, P.K
2002
20 7-8 p. 1163-1168
6 p.
article
26 Keyword Index to: Volume 19 2002
20 7-8 p. XVII-XXXV
nvt p.
article
27 Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines Kim, Y
2002
20 7-8 p. 1248-1258
11 p.
article
28 Mucosal [SIgA] and serum [IgG] immunologic responses in the community after a single intra-nasal immunization with a new inactivated trivalent influenza vaccine Greenbaum, Evgenia
2002
20 7-8 p. 1232-1239
8 p.
article
29 Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine Lu, Xiuhua
2002
20 7-8 p. 1019-1029
11 p.
article
30 Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad–Zagreb mumps strain da Cunha, Sérgio Souza
2002
20 7-8 p. 1106-1112
7 p.
article
31 Oxidised mannan as a novel adjuvant inducing mucosal IgA production Stambas, John
2002
20 7-8 p. 1068-1078
11 p.
article
32 Persistent infection of influenza virus in irradiated mice and its prevention by intranasal vaccination Hasegawa, Hideki
2002
20 7-8 p. 1050-1057
8 p.
article
33 Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets Hong, Wenzhou
2002
20 7-8 p. 1205-1214
10 p.
article
34 Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children Halperin, Scott A
2002
20 7-8 p. 1240-1247
8 p.
article
35 The cost-effectiveness of varicella vaccination in Canada Brisson, M
2002
20 7-8 p. 1113-1125
13 p.
article
36 The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant Scanlen, M
2002
20 7-8 p. 1079-1088
10 p.
article
37 Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine Studdert, Michael J
2002
20 7-8 p. 992-
1 p.
article
38 Vaccine quality—can a single standard be defined? Milstien, Julie
2002
20 7-8 p. 1000-1003
4 p.
article
                             38 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands